0.6846
price down icon2.20%   -0.0154
after-market 시간 외 거래: .69 0.0054 +0.79%
loading

Xilio Therapeutics Inc (XLO) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
기간 3개월 3개월 3개월 3개월 3개월
Revenues
175.90%
8.084
2.93 1.724 2.263 2.357
Operating Expenses
33.78%
22.45
16.78 15.35 17.02 17.06
Benefits Costs and Expenses
100.00%
-
16.20 14.82 - -
Costs And Expenses
38.62%
22.45
16.20 14.82 17.02 17.06
Operating Income/Loss
3.72%
-14.37
-13.85 -13.63 -14.76 -14.70
Nonoperating Income/Loss
352.22%
-1.478
0.586 0.536 0.742 0.779
Income/Loss From Continuing Operations Before Tax
160.94%
8.084
-13.27 -13.09 2.263 2.357
Income/Loss From Continuing Operations After Tax
19.44%
-15.84
-13.27 -13.09 -14.02 -13.93
Net Income/Loss
19.44%
-15.84
-13.27 -13.09 -14.02 -13.93
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
29.11%
96.45
74.70 3.7486 63.47 57.76
Basic Earnings Per Share
11.11%
-0.16
-0.18 -0.18 -0.22 -0.24
Diluted Earnings Per Share
11.11%
-0.16
-0.18 -0.18 -0.22 -0.24
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
자본화:     |  볼륨(24시간):